@nihardesai89@ASH_hematology@drsanjeev1980 @DrAkhilX @GonzaloBentoli1 Would not call this starry sky on marrow aspirate, but classic L3 morphology cells c/w Burkitt leukemia. Confirm with flow cytometery and FISH for MYC transloc. Features of tumor lysis syndrome, check uric acid. Rasburicase, aggressive fluids, correct electrolytes, chemotherapy.
The @TommyFundCT presented Justin Gardner, MEd School Support Coordinator with a generous grant to fund two @Yale student interns to support the educational needs of patients unable to attend school while in treatment. Supply resources for the interns were also donated.
@StefThomasMD I continue to propose someone (not me) should open up a splenomegaly and/or eosinophilia clinic for all these things that are almost always not hem/onc problems
Fascinating talk from James Doroshow @theNCI during #Tandem23 on the need to critically re-examine clinical trial design in the wake of the Pandemic. Trials should be streamlined to reduce burdens to patients and research teams with widespread resource limitations.
Cefdinir is poorly absorbed and highly protein bound. Time > MIC is suboptimal ==> not recommended for CAP.
*Cefdinir does not equal ceftriaxone. It isn't a step up for failed amoxicillin or amoxicillin-clavulanate.
#AAP2022